🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 22 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/06/2003 49,35 51,00 49,35 50,57 +2,58% 3,34% 506.900
24/06/2003 50,19 50,50 48,67 49,30 -0,98% 3,65% 486.200
23/06/2003 50,74 51,00 48,75 49,79 -1,70% 4,43% 471.400
20/06/2003 50,38 51,45 49,52 50,65 +1,24% 3,83% 727.000
19/06/2003 53,51 54,05 48,88 50,03 -7,28% 9,66% 1.110.300
18/06/2003 55,82 56,16 53,43 53,96 -3,35% 4,89% 410.100
17/06/2003 57,30 58,02 53,25 55,83 -3,14% 8,32% 825.900
16/06/2003 55,00 58,24 54,83 57,64 +4,69% 6,20% 604.200
13/06/2003 53,68 55,86 53,67 55,06 +2,92% 4,08% 577.000
12/06/2003 53,38 54,26 53,00 53,50 +0,47% 2,36% 508.000
11/06/2003 52,30 53,94 52,20 53,25 +2,11% 3,33% 981.800
10/06/2003 53,55 54,72 51,75 52,15 -2,27% 5,55% 526.700
09/06/2003 56,53 56,56 52,55 53,36 -6,12% 7,09% 984.000
06/06/2003 56,77 60,27 54,31 56,84 -0,30% 10,50% 1.463.900
05/06/2003 52,02 57,04 51,32 57,01 +9,93% 11,00% 851.900
04/06/2003 52,00 52,95 51,65 51,86 +0,04% 2,50% 484.500
03/06/2003 51,85 52,45 51,24 51,84 -0,06% 2,33% 281.000
02/06/2003 50,98 52,79 50,81 51,87 +2,31% 3,88% 678.000
30/05/2003 50,02 50,95 49,85 50,70 +1,99% 2,20% 297.100
29/05/2003 49,80 50,70 49,71 49,71 +0,18% 1,99% 381.500
28/05/2003 51,20 52,45 49,43 49,62 -3,07% 5,90% 528.200
27/05/2003 48,78 51,51 48,60 51,19 +4,98% 5,97% 849.400
23/05/2003 48,44 49,04 47,84 48,76 +0,52% 2,48% 214.100
22/05/2003 48,02 48,63 47,60 48,51 +0,94% 2,14% 423.800
21/05/2003 47,21 48,07 46,98 48,06 +1,29% 2,31% 263.300
20/05/2003 47,91 48,39 46,79 47,45 -0,88% 3,34% 280.000
19/05/2003 48,31 49,20 47,45 47,87 -2,68% 3,62% 381.000
16/05/2003 49,01 49,27 47,99 49,19 -0,04% 2,61% 311.900
15/05/2003 49,42 49,95 48,66 49,21 -0,73% 2,61% 432.700
14/05/2003 47,13 49,63 47,12 49,57 +4,95% 5,33% 606.900